COVID-19 adaptive humoral immunity models: non-neutralizing versus antibody-disease enhancement scenarios
View ORCID ProfileAntoine Danchin, Oriane Pagani-Azizi, View ORCID ProfileGabriel Turinici, View ORCID ProfileGhozlane Yahiaoui
doi: https://doi.org/10.1101/2020.10.21.20216713
Antoine Danchin
†Institut Cochin, Paris, France
Oriane Pagani-Azizi
‡CEREMADE - ESPCI Paris PSL, Paris, France
Gabriel Turinici
§Université Paris Dauphine - PSL Research University, Paris, France
Ghozlane Yahiaoui
¶Mathematical Institute, University of Oxford, Oxford, United Kingdom
Data Availability
All data is available from public sources.
Posted October 23, 2020.
COVID-19 adaptive humoral immunity models: non-neutralizing versus antibody-disease enhancement scenarios
Antoine Danchin, Oriane Pagani-Azizi, Gabriel Turinici, Ghozlane Yahiaoui
medRxiv 2020.10.21.20216713; doi: https://doi.org/10.1101/2020.10.21.20216713
Subject Area
Subject Areas
- Addiction Medicine (317)
- Allergy and Immunology (621)
- Anesthesia (162)
- Cardiovascular Medicine (2322)
- Dermatology (205)
- Emergency Medicine (373)
- Epidemiology (11655)
- Forensic Medicine (10)
- Gastroenterology (689)
- Genetic and Genomic Medicine (3657)
- Geriatric Medicine (344)
- Health Economics (626)
- Health Informatics (2341)
- Health Policy (922)
- Hematology (337)
- HIV/AIDS (765)
- Medical Education (362)
- Medical Ethics (103)
- Nephrology (394)
- Neurology (3408)
- Nursing (193)
- Nutrition (512)
- Oncology (1788)
- Ophthalmology (529)
- Orthopedics (212)
- Otolaryngology (284)
- Pain Medicine (227)
- Palliative Medicine (66)
- Pathology (442)
- Pediatrics (1016)
- Primary Care Research (411)
- Public and Global Health (6048)
- Radiology and Imaging (1243)
- Respiratory Medicine (816)
- Rheumatology (373)
- Sports Medicine (319)
- Surgery (392)
- Toxicology (50)
- Transplantation (171)
- Urology (144)